Albert C Shen, MD
Internal Medicine · San Jose
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- 25
- 6 carriers
- Office
- 1
On the public record
- California licence: Delinquent
Offices
1 location
Looking this up.
Plans that list them
25 plans · 6 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Shen’s office at (408) 296-9800 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
25 of 25 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence G75131 · Delinquent
Licence status: Delinquent · since 1992 · expires 2024-08-31 · Columbia University College of Physicians and Surgeons.
License renewal fee has not been paid. No practice is permitted.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$13,900
Medicare paid this office $13,900 for 51 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 36 | $4,917 | $82 |
| Short return visit (20+ min) | 35 | $4,527 | $70 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 16 | $2,207 | $138 |
Procedures Medicare counted
| Removal of skin lesions | 1-10 | None |
Who their Medicare patients are
51 Original Medicare patients in 2024. Average age 73 · Under 65 0% · Women 43% · Health risk score 0.71. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 71% · Diabetes 22%.
The office billed $26,974, Medicare allowed $20,397 and paid $13,900; for 181 services of 12 kinds; $989 of it was for drugs given in the office and $12,910 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 51 | 181 | 73 | 0.71 | $26,974 | $13,900 |
| 2023 | 41 | 151 | 73 | 0.69 | $22,247 | $10,550 |
| 2022 | 45 | 142 | 73 | 0.65 | $21,444 | $10,786 |
| 2021 | 37 | 130 | 73 | 0.85 | $20,405 | $11,072 |
| 2020 | 41 | 171 | 73 | 0.90 | $26,421 | $11,134 |
| 2019 | 27 | 123 | 73 | 1.00 | $13,403 | $8,614 |
| 2018 | 27 | 100 | 72 | 1.47 | $10,866 | $5,849 |
| 2017 | 27 | 99 | 72 | 1.07 | $10,611 | $6,061 |
| 2016 | 30 | 117 | 75 | 0.98 | $13,279 | $7,693 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Return visit (30+ min) | 22 | $4,675 | $97 |
| Short return visit (20+ min) | 25 | $2,215 | $53 |
| Administration of influenza virus vaccine | 12 | $412 | $34 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 12 | $263 | $22 |
2022: 5 services
| Return visit (30+ min) | 27 | $4,275 | $93 |
| Short return visit (20+ min) | 24 | $2,726 | $70 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 16 | $2,224 | $139 |
| Administration of influenza virus vaccine | 11 | $377 | $34 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 14 | $295 | $21 |
2021: 3 services
| Return visit (30+ min) | 20 | $4,077 | $105 |
| Short return visit (20+ min) | 16 | $3,134 | $80 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 17 | $2,393 | $141 |
2020: 3 services
| Return visit (30+ min) | 23 | $4,053 | $79 |
| Short return visit (20+ min) | 23 | $3,123 | $52 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 13 | $254 | $20 |
2019: 5 services
| Return visit (30+ min) | 19 | $3,275 | $86 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 15 | $1,982 | $132 |
| Short return visit (20+ min) | 12 | $1,006 | $53 |
| Administration of influenza virus vaccine | 12 | $267 | $21 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 13 | $261 | $19 |
2018: 2 services
| Return visit (30+ min) | 20 | $2,151 | $67 |
| Short return visit (20+ min) | 13 | $964 | $42 |
2017: 2 services
| Return visit (30+ min) | 19 | $2,986 | $73 |
| Short return visit (20+ min) | 12 | $998 | $53 |
2016: 2 services
| Return visit (30+ min) | 16 | $2,930 | $86 |
| Short return visit (20+ min) | 16 | $1,891 | $63 |
Medicaid work
$246,583 in 2024
Medicaid paid $246,583 for 7,949 billed services this clinician did in 2024, up to 239 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 1,886 | $244,787 |
| Short return visit (20+ min) | 1,513 | $797 |
| Return visit (30+ min) | 706 | $599 |
| New patient visit (30+ min) | 241 | $353 |
| Short return visit | 20 | $36 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Streptococcus, group A | 432 | $10 |
| Pain severity quantified; pain present (COA) (ONC) | 131 | $0 |
| Pain severity quantified; no pain present (COA) (ONC) | 75 | $0 |
| Medication list documented in medical record (COA) | 1,527 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 709 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 640 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 24 | $0 |
| 2024 | 7,949 | 14 | 239 | $246,583 |
| 2023 | 4,836 | 10 | 183 | $261,093 |
| 2022 | 3,916 | 7 | 219 | $163,775 |
| 2021 | 13 | 1 | 13 | $7,683 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 1,984 | $256,134 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) | 94 | $1,619 |
| Service | 33 | $1,420 |
| Short return visit (20+ min) | 1,798 | $1,403 |
| New patient visit (30+ min) | 178 | $405 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Streptococcus, group A | 347 | $56 |
| Short return visit | 170 | $56 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 108 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 90 | $0 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 34 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 1,569 | $149,899 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) | 325 | $7,800 |
| Short return visit (20+ min) | 1,198 | $3,206 |
| Service | 33 | $1,420 |
| Short return visit | 599 | $1,413 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Streptococcus, group A | 173 | $36 |
| Developmental screening | 19 | $0 |
2021
| Clinic visit/encounter, all-inclusive | 13 | $7,683 |
Drugs they prescribed that Part D paid
$61,147
Pharmacies billed $61,147 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (13 of 1,552) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
1,403 generic and fewer than 11 brand-name prescriptions · $61,147 in drug cost · 30 antibiotic prescriptions to 26 people · 15 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 22 | $26,209 | $1,191 |
| Atorvastatin | 249 | $1,709 | $7 |
| Losartan | 145 | $1,305 | $9 |
| Celecoxib | 25 | $969 | $39 |
| Albuterol Sulfate Hfa | 38 | $824 | $22 |
See all 27 drugs
| Jardiance | 22 | $26,209 | $1,191 |
| Atorvastatin | 249 | $1,709 | $7 |
| Losartan | 145 | $1,305 | $9 |
| Celecoxib | 25 | $969 | $39 |
| Albuterol Sulfate Hfa | 38 | $824 | $22 |
| Alendronate | 84 | $663 | $8 |
| Metformin | 85 | $578 | $7 |
| Levothyroxine | 54 | $537 | $10 |
| Simvastatin | 46 | $436 | $9 |
| Olmesartan Medoxomil | 17 | $425 | $25 |
| Amlodipine Besylate | 81 | $263 | $3 |
| Lisinopril | 40 | $255 | $6 |
| Metoprolol | 11 | $213 | $19 |
| Ipratropium | 15 | $208 | $14 |
| Fluoxetine | 24 | $186 | $8 |
| Terazosin | 18 | $174 | $10 |
| Glyburide | 21 | $168 | $8 |
| Fluticasone Propionate | 34 | $156 | $5 |
| Tamsulosin | 18 | $132 | $7 |
| Rosuvastatin | 20 | $131 | $7 |
| Montelukast | 21 | $130 | $6 |
| Omeprazole | 28 | $87 | $3 |
| Triamcinolone Acetonide | 17 | $69 | $4 |
| Hydrochlorothiazide | 13 | $44 | $3 |
| Tizanidine | 22 | $29 | $1 |
| Sulfamethoxazole-Trimethoprim | 13 | $25 | $2 |
| Mupirocin | 11 | $13 | $1 |
Year by year
| 2024 | 1,552 | 124 | 1% (13) | None | $61,147 |
| 2023 | 1,208 | 101 | 1% (17) | 7% | $46,963 |
| 2022 | 907 | 95 | 1% (11) | None | $31,596 |
| 2021 | 737 | 75 | 2% (13) | 7% | $27,246 |
| 2020 | 685 | 66 | None | None | $25,121 |
| 2019 | 466 | 52 | 0% (0) | 9% | $15,103 |
| 2018 | 451 | 42 | None | None | $11,393 |
| 2017 | 339 | 35 | None | 10% | $11,182 |
| 2016 | 251 | 24 | 0% (0) | None | $13,254 |
| 2015 | 213 | 16 | 0% (0) | None | $11,410 |
| 2014 | 174 | 16 | 0% (0) | 34% | $9,158 |
| 2013 | 163 | 16 | None | 23% | $6,481 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 23 drugs
| Jardiance | 11 | $17,949 | $1,632 |
| Atorvastatin | 189 | $2,967 | $16 |
| Losartan | 127 | $2,279 | $18 |
| Metformin | 73 | $1,079 | $15 |
| Alendronate | 53 | $979 | $18 |
| Celecoxib | 17 | $920 | $54 |
| Simvastatin | 45 | $650 | $14 |
| Albuterol Sulfate Hfa | 30 | $633 | $21 |
| Amlodipine Besylate | 60 | $601 | $10 |
| Levothyroxine | 41 | $524 | $13 |
| Lisinopril | 33 | $494 | $15 |
| Tamsulosin | 15 | $471 | $31 |
| Fluticasone Propionate | 37 | $426 | $12 |
| Olmesartan Medoxomil | 11 | $375 | $34 |
| Omeprazole | 41 | $321 | $8 |
| Terazosin | 13 | $202 | $16 |
| Glyburide | 11 | $199 | $18 |
| Triamcinolone Acetonide | 14 | $199 | $14 |
| Hydrochlorothiazide | 13 | $145 | $11 |
| Montelukast | 12 | $111 | $9 |
| Famotidine | 15 | $65 | $4 |
| Tramadol | 12 | $32 | $3 |
| Tizanidine | 16 | $22 | $1 |
2022: 18 drugs
| Jardiance | 12 | $13,474 | $1,123 |
| Atorvastatin | 142 | $1,848 | $13 |
| Losartan | 108 | $1,555 | $14 |
| Albuterol Sulfate Hfa | 15 | $879 | $59 |
| Metformin | 59 | $648 | $11 |
| Amlodipine Besylate | 67 | $465 | $7 |
| Lisinopril | 38 | $450 | $12 |
| Levothyroxine | 26 | $390 | $15 |
| Tamsulosin | 21 | $388 | $18 |
| Alendronate | 56 | $377 | $7 |
| Glyburide | 13 | $350 | $27 |
| Simvastatin | 30 | $316 | $11 |
| Montelukast | 14 | $211 | $15 |
| Terazosin | 17 | $192 | $11 |
| Fluticasone Propionate | 15 | $163 | $11 |
| Omeprazole | 17 | $94 | $6 |
| Trazodone | 11 | $25 | $2 |
| Tramadol | 11 | $20 | $2 |
2021: 15 drugs
| Jardiance | 17 | $12,218 | $719 |
| Atorvastatin | 94 | $1,427 | $15 |
| Losartan | 77 | $1,359 | $18 |
| Metformin | 54 | $778 | $14 |
| Alendronate | 48 | $526 | $11 |
| Tamsulosin | 25 | $487 | $19 |
| Simvastatin | 37 | $445 | $12 |
| Levothyroxine | 20 | $419 | $21 |
| Amlodipine Besylate | 52 | $409 | $8 |
| Celecoxib | 12 | $381 | $32 |
| Lisinopril | 29 | $305 | $11 |
| Glyburide | 13 | $299 | $23 |
| Montelukast | 11 | $121 | $11 |
| Gabapentin | 11 | $71 | $6 |
| Tramadol | 12 | $49 | $4 |
2020: 13 drugs
| Atorvastatin | 68 | $1,295 | $19 |
| Losartan | 62 | $820 | $13 |
| Albuterol Sulfate Hfa | 14 | $606 | $43 |
| Metformin | 42 | $486 | $12 |
| Alendronate | 44 | $457 | $10 |
| Tamsulosin | 27 | $420 | $16 |
| Simvastatin | 30 | $319 | $11 |
| Lisinopril | 27 | $286 | $11 |
| Paroxetine | 13 | $269 | $21 |
| Amlodipine Besylate | 45 | $233 | $5 |
| Omeprazole | 32 | $189 | $6 |
| Glyburide | 11 | $175 | $16 |
| Fluticasone Propionate | 12 | $144 | $12 |
2019: 8 drugs
| Losartan | 72 | $1,045 | $15 |
| Atorvastatin | 44 | $646 | $15 |
| Alendronate | 39 | $508 | $13 |
| Amlodipine Besylate | 45 | $460 | $10 |
| Metformin | 29 | $419 | $14 |
| Tamsulosin | 12 | $326 | $27 |
| Simvastatin | 24 | $313 | $13 |
| Lisinopril | 19 | $164 | $9 |
2018: 8 drugs
| Losartan | 61 | $737 | $12 |
| Atorvastatin | 32 | $554 | $17 |
| Alendronate | 46 | $447 | $10 |
| Metformin | 27 | $413 | $15 |
| Amlodipine Besylate | 35 | $262 | $7 |
| Simvastatin | 23 | $214 | $9 |
| Lisinopril | 20 | $170 | $8 |
| Hydrochlorothiazide | 16 | $105 | $7 |
2017: 9 drugs
| Valsartan | 13 | $562 | $43 |
| Ultra-Fine Short Pen Needle | 11 | $531 | $48 |
| Losartan | 28 | $352 | $13 |
| Amlodipine Besylate | 34 | $310 | $9 |
| Metformin | 17 | $307 | $18 |
| Atorvastatin | 13 | $297 | $23 |
| Alendronate | 35 | $283 | $8 |
| Lisinopril | 15 | $192 | $13 |
| Simvastatin | 18 | $155 | $9 |
2016: 6 drugs
| Alendronate | 31 | $234 | $8 |
| Simvastatin | 19 | $163 | $9 |
| Metformin | 11 | $100 | $9 |
| Losartan | 13 | $99 | $8 |
| Lisinopril | 11 | $82 | $7 |
| Amlodipine Besylate | 17 | $58 | $3 |
2015: 4 drugs
| Alendronate | 16 | $110 | $7 |
| Paroxetine | 12 | $86 | $7 |
| Simvastatin | 16 | $77 | $5 |
| Amlodipine Besylate | 14 | $41 | $3 |
2014: 2 drugs
| Synthroid | 11 | $663 | $60 |
| Alendronate | 14 | $223 | $16 |
2013: 3 drugs
| Omeprazole | 12 | $374 | $31 |
| Levothyroxine | 16 | $180 | $11 |
| Paroxetine | 12 | $116 | $10 |
Money from drug and device companies
$131 in 2025
| 2025 | 1 | 1 | None | $131 |
| 2024 | 2 | 2 | None | $180 |
| 2023 | 1 | 1 | None | $15 |
| 2021 | 1 | 1 | None | $25 |
| 2019 | 2 | 2 | $25 | $38 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Shockwave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $131 | 1 payment
|
See the published payment
| Shockwave Medical | Meals · 2025-02-04 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $131 |
See earlier years (2024, 2023, 2021, 2019)
2024: $180
| Abbott Laboratories | Pressurewire | $150 | 1 payment
|
| Merck Sharp & Dohme | Gardasil | $30 | 1 payment
|
2023: $15
| Cranial Technologies | Doc Band | $15 | 1 payment
|
2021: $25
| Merck Sharp & Dohme | Gardasil 9 | $25 | 1 payment
|
2019: $38
| GlaxoSmithKline | Rotarix | $25 | 1 payment
|
| Sanofi Pasteur | Adacel | $13 | 1 payment
|
Professional record
- NPI
- 1851481758
- Licence
- CA G75131California G75131: Delinquent · expires 2024-08-31
- Trained
- Chicago College of Medicine and Surgery, 1994
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Internal medicine (207R00000X); Pediatrics (208000000X)
- Mailing address
- 316 Rosewood Ave, San Jose, CA, 95117
- NPI first listed
- 2006-10-13
- NPI last updated
- 2015-07-16
This is when the NPI record was last certified, not a medical board exam.